Literature DB >> 7633123

Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma.

K Sugino1, Y Kure, H Iwasaki, O Ozaki, T Mimura, A Matsumoto, K Ito.   

Abstract

To investigate the biological characteristics of papillary thyroid carcinoma from the perspectives of lymph node metastasis, lymph node recurrence, and distant metastasis, 746 patients with nonadvanced papillary thyroid carcinoma were retrospectively studied. There were 76 men and 670 women with a mean age of 42.7 years. The rate of lymph node metastasis was significantly higher in young patients (aged less than 30 years). Lymph node recurrence was observed in 80 patients and distant metastasis in 13, being seen with significant frequency in the young and elderly (aged over 50 years) patients and in the men. The frequency of distant metastasis was significantly greater in the elderly patients and in those with lymph node recurrence. These findings indicate that the role of regional lymph nodes and the clinical meaning of lymph node recurrence differ between young and elderly patients.

Entities:  

Mesh:

Year:  1995        PMID: 7633123     DOI: 10.1007/bf00311254

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

1.  Surgical treatment of locally advanced thyroid cancer.

Authors:  K Sugino; Y Kure; O Ozaki; K Ito; A Matsumoto
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

2.  Operative strategy for thyroid cancer. Is total thyroidectomy worth the price?

Authors:  D M Schroder; A Chambors; C J France
Journal:  Cancer       Date:  1986-11-15       Impact factor: 6.860

3.  Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment.

Authors:  H R Tollefsen; J P Shah; A G Huvos
Journal:  Am J Surg       Date:  1972-10       Impact factor: 2.565

4.  Selection of surgical treatment for well differentiated thyroid carcinomas.

Authors:  J A Buckwalter; C G Thomas
Journal:  Ann Surg       Date:  1972-10       Impact factor: 12.969

Review 5.  The value of lymph-node dissection in patients with differentiated thyroid cancer.

Authors:  S Noguchi; N Murakami
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

6.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

7.  Risk factor analysis in differentiated thyroid cancer.

Authors:  B Cady; C E Sedgwick; W A Meissner; M S Wool; F A Salzman; J Werber
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

8.  Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome.

Authors:  W M McConahey; I D Hay; L B Woolner; J A van Heerden; W F Taylor
Journal:  Mayo Clin Proc       Date:  1986-12       Impact factor: 7.616

9.  Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients.

Authors:  E L Mazzaferri; R L Young
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

10.  Long-term results and prognostic factors in patients with differentiated thyroid carcinoma.

Authors:  M Tubiana; M Schlumberger; P Rougier; A Laplanche; E Benhamou; P Gardet; B Caillou; J P Travagli; C Parmentier
Journal:  Cancer       Date:  1985-02-15       Impact factor: 6.860

View more
  10 in total

Review 1.  Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis.

Authors:  Huy Gia Vuong; Uyen N P Duong; Thong Quang Pham; Hung Minh Tran; Naoki Oishi; Kunio Mochizuki; Tadao Nakazawa; Lewis Hassell; Ryohei Katoh; Tetsuo Kondo
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

2.  Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer.

Authors:  Fabián Pitoia; Fernando Jerkovich; Anabella Smulever; Gabriela Brenta; Fernanda Bueno; Graciela Cross
Journal:  Eur Thyroid J       Date:  2017-01-07

3.  Retrospective analysis of predictive factors for recurrence after curatively resected papillary thyroid carcinoma.

Authors:  Katsuhiro Tanaka; Hiroshi Sonoo; Mai Hirono; Sumiko Ohkubo; Tsunehisa Nomura; Masahiko Ikeda; Kazukata Nakajima; Junichi Kurebayashi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection.

Authors:  Nobuyuki Wada; Quan-Yang Duh; Kiminori Sugino; Hiroyuki Iwasaki; Kaori Kameyama; Takashi Mimura; Koichi Ito; Hiroshi Takami; Yoshinori Takanashi
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

5.  Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes.

Authors:  Nobuyuki Wada; Nobuyasu Suganuma; Hirotaka Nakayama; Katsuhiko Masudo; Yasushi Rino; Munetaka Masuda; Toshio Imada
Journal:  Langenbecks Arch Surg       Date:  2007-02-16       Impact factor: 3.445

6.  Papillary microcarcinoma of the thyroid.

Authors:  K Sugino; K Ito; O Ozaki; T Mimura; H Iwasaki; K Ito
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

7.  Is There Justification for Total Thyroidectomy in Low-Risk Papillary Thyroid Carcinoma? A Decision-Analysis Model.

Authors:  Sagit Stern; Ohad Hilly; Einav Horowitz; Moshe Leshno; Raphael Feinmesser
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

8.  TFF3 Contributes to Epithelial-Mesenchymal Transition (EMT) in Papillary Thyroid Carcinoma Cells via the MAPK/ERK Signaling Pathway.

Authors:  Xu Lin; Huiqin Zhang; Jin Dai; Wenjing Zhang; Jing Zhang; Gang Xue; Jingfang Wu
Journal:  J Cancer       Date:  2018-10-31       Impact factor: 4.207

9.  Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.

Authors:  Weixin Liang; Yongqiang Lai; Mingzhang Zhu; Shangshu Huang; Weizhao Feng; Xiaoyu Gu
Journal:  Med Sci Monit       Date:  2016-12-14

10.  The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer.

Authors:  Xiaofei Wang; Jingqiang Zhu; Zhihui Li; Tao Wei
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.